The executive regulations of a new law on blood operations and collecting plasma for manufacturing and exporting plasma derivatives will contribute to the accurate application of the law, Prime Minister Mostafa Madbouli said Sunday.
Madbouli also emphasized the major importance of a national project adopted and regularly followed up by President Abdel Abdel Fattah El Sisi to regulate blood operations for these purpose to secure the country’s needs of plasma derivatives and reduce dependence on blood plasma exports, leading to ensuring drug security.
The premier made the remarks during a meeting to discuss the draft executive regulations with the ministers of health, higher education and scientific research, and justice.
Board Chairman of the Egyptian Authority for Unified Procurement, Medical Supply and Technology Management (AUPP) Bahaa Eddin Zidan, Chairman of the Egyptian Drug Authority (EDA) Tamer Essam, and head of the health ministry’s central administration for technical support Nevin El-Nahhas were also in attendance.
In addition to the definitions of relevant legal terms and concepts, the six-chapter document sets forth the measures to regulate blood operations, such as the licensing procedures for blood and plasma donation centers, Cabinet Spokesman Nader Saad said in a statement.
It also includes a set of general provisions about the donation process and the tests needed before donating or using blood plasma.
As per the premier’s instructions during the meeting, the final draft will be agreed within a maximum period of one week.
Source: State Information Service Egypt